Ketoconazole (Topical)
Also known as: Nizoral, Nizoral A-D, KCZ, Keto shampoo
Lower numbers = closer to natural. Higher numbers = more enhanced.
Why this rating?
A topical antifungal shampoo. It has no anabolic, androgenic or ergogenic action and essentially no systemic absorption when used as a shampoo. Its role here is purely as a hair-loss adjunct, so it does not move the natural ceiling by any path. Rated 1 (basically natty).
Overview
An antifungal shampoo that became a hair-loss adjunct after a 1998 study found the 2% formulation improved hair density comparably to 2% minoxidil. It is the third leg of the community "big three" (minoxidil, finasteride, ketoconazole), but the evidence behind it is genuinely thin compared with the other two, and the authors of the key study said as much themselves.
Important Warnings
- •Use for hair loss is off-label, no ketoconazole product is approved for androgenetic alopecia
- •The supporting evidence is one small 1998 study whose authors called for larger confirmatory work that never followed
- •It is an adjunct, not a treatment. It will not hold hair on its own during a cycle
- •Do NOT substitute oral ketoconazole, which carries real hepatotoxicity and CYP3A4 interaction risk
- •Contact time of 3-5 minutes is required; rinsing immediately does little
Purpose & Use Cases
Adjunct In Androgenetic Alopecia
Used two to four times weekly alongside minoxidil and a 5-AR inhibitor. It is an add-on, not a primary treatment. Nobody credible treats hair loss with ketoconazole alone.
Controlling Scalp Inflammation And Seborrheic Dermatitis
This is the part that is actually well-established. Scalp inflammation and seborrheic dermatitis are common in AAS users (sebum production rises with androgens) and a chronically inflamed scalp is a poor environment for follicles.
Managing Cycle-Driven Sebum And Dandruff
Elevated androgens increase sebum output, which feeds Malassezia. Ketoconazole addresses that directly and is often the simplest fix for the greasy, flaking scalp that shows up on-cycle.
Benefits
- The one part of the "big three" with essentially no side effect burden
- Piérard-Franchimont 1998 found hair density, hair size and anagen proportion improved almost similarly by 2% ketoconazole and 2% minoxidil regimens
- Reduces scalp sebum, which rises on-cycle with elevated androgens
- Well-established for seborrheic dermatitis and dandruff independent of the hair-loss claim
- No systemic absorption of consequence, no hormonal interaction, no PCT implications
- Cheap, and can simply replace your existing shampoo
Good to Know
The evidence is thinner than the reputation
The "big three" status rests largely on one 1998 study in Dermatology by Piérard-Franchimont and colleagues, which found hair density, hair size and anagen proportion improved almost similarly by 2% ketoconazole and 2% minoxidil. The authors themselves closed by saying the clinical significance awaited further controlled study in a larger group. That larger confirmatory study never really materialised.
Topical ketoconazole is not oral ketoconazole
Oral ketoconazole is a systemic antifungal with meaningful hepatotoxicity, adrenal suppression at high doses and heavy CYP3A4 interactions, which is why its systemic use has been restricted. None of that applies to a shampoo you rinse off. Do not take the oral drug for hair.
Contact time is the whole protocol
The drug has to sit on the scalp to do anything. Lather, leave it 3-5 minutes, then rinse. Washing it straight out is the most common way people get nothing from it.
It addresses a real on-cycle problem regardless of the hair claim
Elevated androgens raise sebum output, which feeds Malassezia and drives dandruff and seborrheic dermatitis. Even setting the alopecia evidence aside, that is a legitimate and well-supported use during a cycle.
Dosage Guidelines
| Experience Level | Dosage Range |
|---|---|
| Beginner | 1 – 2 washes/week |
| Intermediate | 2 – 4 washes/week |
There is no established dose-response for the hair-loss use, because it has never been properly dose-ranged for that indication. 2-4 washes weekly is the common practical schedule rather than a validated protocol. The 2% strength is the one used in the Piérard-Franchimont study; the OTC 1% is weaker. Used indefinitely rather than in cycles, like any shampoo. Note the study authors explicitly concluded that "the clinical significance of the results awaits further controlled study in a larger group of subjects". Treat this as a low-cost adjunct with modest evidence, not a proven treatment.
Used as a shampoo and rinsed off, systemic absorption is negligible. The pharmacokinetics that matter for oral ketoconazole (a drug with real hepatotoxicity and CYP3A4 interaction concerns) do not apply to the topical shampoo.
Side Effects
Scalp irritation / dryness
uncommonItching, dryness or a burning sensation at the application site.
Reduce frequency, shorten contact time, or follow with conditioner.
Hair texture changes
uncommonDryness or altered texture from repeated use, as with any medicated shampoo.
Alternate with a normal shampoo on non-treatment days.
Allergic contact dermatitis
rareHypersensitivity to ketoconazole or a formulation excipient.
Discontinue. Patch test if reintroducing a different formulation.
General Mitigation Strategies
This is about as benign as an intervention gets. It is a rinsed-off topical with negligible systemic absorption. The hepatotoxicity and drug-interaction warnings attached to ORAL ketoconazole (a genuinely problematic systemic antifungal) do not transfer to the shampoo, and conflating the two is a common error. Local irritation is the realistic worst case.
Post Cycle Therapy (PCT)
No HPT axis interaction. No PCT implications.
How It Works
Ketoconazole is an imidazole antifungal that inhibits fungal ergosterol synthesis, which is how it controls Malassezia and the seborrheic dermatitis/dandruff it drives. Two further properties are the basis for its use in androgenetic alopecia: it has intrinsic anti-inflammatory activity, and it reduces scalp sebum (the 1998 Piérard-Franchimont study found the sebum casual level appeared to be decreased by ketoconazole). A local anti-androgenic action has also been proposed, but this is not established for the topical route at shampoo concentrations.
Hormonal & Androgenic Profile
N/A: not an androgen.
No aromatase or estrogen relevance at topical shampoo exposure.
A local anti-androgenic effect has been proposed as part of its mechanism in alopecia, but this is not established for the topical route at shampoo concentrations. Do not count on it as a DHT intervention. It does not replace finasteride or dutasteride.
None. Negligible systemic exposure from the topical route.
Fundamentals
Reference on the practices relevant to Ketoconazole (Topical): how they are done and where they go wrong. Not a recommendation to use it.
Common Stacks
- Minoxidil + Finasteride + Ketoconazole: the community "big three"
- Ketoconazole alongside any cycle that increases sebum and scalp flaking
- Ketoconazole + Isotretinoin: reduce wash frequency, both are drying
Legal Status
In the US the 1% shampoo (Nizoral A-D) is available over the counter for dandruff in ages 12+, while the 2% strength is prescription and FDA-approved for tinea (pityriasis) versicolor. Use for androgenetic alopecia is OFF-LABEL for both strengths, no ketoconazole product is approved for hair loss anywhere. Availability of the 2% without prescription varies by country.
Legal status varies by country and changes over time. This is a general summary, not legal advice.
WADA Status
A topical antifungal with no performance-enhancing action. Not listed on the WADA Prohibited List.
References
- Dermatology (1998), Ketoconazole Shampoo: Effect of Long-Term Use in Androgenic Alopecia (Piérard-Franchimont et al.)
- Karger, Ketoconazole Shampoo: Effect of Long-Term Use in Androgenic Alopecia (abstract)
- DailyMed, Ketoconazole Shampoo 2% label (FDA-approved indication: tinea versicolor)
- FDA, Nizoral (ketoconazole) 2% shampoo label